Maintenance of efficacy and safety with subcutaneous golimumab among patients with active rheumatoid arthritis who previously received intravenous golimumab.

Míreanna comhchosúla

• THE EFFECT OF GOLIMUMAB ON ARTERIAL STIFFNESS IN PATIENTS WITH RHEUMATOID ARTHRITIS
  de réir: L. A. Knyazeva, et al.
  Foilsithe / Cruthaithe: (2018-03-01)
• Golimumab for the treatment of psoriatic arthritis
  de réir: H Yang, et al.
  Foilsithe / Cruthaithe: (2011-05-01)
• Long-term effectiveness and safety of infliximab, golimumab and golimumab-IV in rheumatoid arthritis patients from a Canadian prospective observational registry
  de réir: Proton Rahman, et al.
  Foilsithe / Cruthaithe: (2020-09-01)
• Golimumab, a new human anti-tumor necrosis factor alpha antibody, administered intravenously in patients with active rheumatoid arthritis: Forty-eight-week efficacy and safety results of a phase III randomized, double-blind, placebo-controlled study.
  de réir: Kremer, J, et al.
  Foilsithe / Cruthaithe: (2010)
• Why golimumab in the treatment of psoriatic arthritis, ankylosing spondylitis and rheumatoid arthritis?
  de réir: M. Rossini, et al.
  Foilsithe / Cruthaithe: (2015-03-01)